Sustained Clinical Benefit of Pyrotinib Combined with Capecitabine Rescue Therapy After Trastuzumab Resistance in HER2-Positive Advanced Gastric Cancer: A Case Report
Xin Li,1,* Xiaoqiang Gu,1,* Jiahua Xu,1,* Ling Chen,2,* Hongwei Li,1 Dan Meng,1 Haoran Bai,1 Jinzu Yang,1 Jianxin Qian1 1Department of Oncology, Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine (TCM), Shanghai, 200032, People’s Republ...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2021-07-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/sustained-clinical-benefit-of-pyrotinib-combined-with-capecitabine-res-peer-reviewed-fulltext-article-OTT |